Page last updated: 2024-08-24

triazoles and gw 501516

triazoles has been researched along with gw 501516 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akita, N; Fukutomi, T; Gonzalez, FJ; Hossain, MA; Kimura, G; Ogata, M; Staels, B; Suzuki, S; Tsujita, M; Yokoyama, S	1
Aasen, AJ; Ciocoiu, CC; Hansen, TV; Nguyen, HH; Nikolić, N; Thoresen, GH	1
Chew, GT; Sahebkar, A; Watts, GF	1

Reviews

1 review(s) available for triazoles and gw 501516

Article	Year
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:4 Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides	2014

Article

Year

New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.

Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:4

Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides

2014

Other Studies

2 other study(ies) available for triazoles and gw 501516

Article	Year
On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis, 2009, Volume: 205, Issue:2 Topics: Animals; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Bezafibrate; Cell Line, Tumor; Fenofibrate; Fibroblasts; Gemfibrozil; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pioglitazone; PPAR delta; PPAR gamma; Propionates; Thiazoles; Thiazolidinediones; Triazoles	2009
Synthesis and dual PPARalpha/delta agonist effects of 1,4-disubstituted 1,2,3-triazole analogues of GW 501516. European journal of medicinal chemistry, 2010, Volume: 45, Issue:7 Topics: Animals; Chlorocebus aethiops; COS Cells; Humans; PPAR alpha; PPAR delta; Thiazoles; Triazoles	2010

Article

Year

On the mechanism for PPAR agonists to enhance ABCA1 gene expression.

Atherosclerosis, 2009, Volume: 205, Issue:2

Topics: Animals; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Bezafibrate; Cell Line, Tumor; Fenofibrate; Fibroblasts; Gemfibrozil; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pioglitazone; PPAR delta; PPAR gamma; Propionates; Thiazoles; Thiazolidinediones; Triazoles

2009

Synthesis and dual PPARalpha/delta agonist effects of 1,4-disubstituted 1,2,3-triazole analogues of GW 501516.

European journal of medicinal chemistry, 2010, Volume: 45, Issue:7

Topics: Animals; Chlorocebus aethiops; COS Cells; Humans; PPAR alpha; PPAR delta; Thiazoles; Triazoles

2010